Skip to main content

IPO Chilli Ratings

IPO Chilli Ratings
Click to understand how it works

Featured

Singapore Institute of Advanced Medicine Holdings Ltd

Singapore Institute of Advanced Medicine Holdings Ltd ("Sam" or the "Company") is offering 114m new shares comprising 4.415m Public Offer Shares and 109.585m Placement Shares at $0.23 each for a listing on Catalist.  The Company aims to raise $26.2m and the majority of the proceeds will be used to repay debt and the balance for working capital. The market cap based on the IPO price is $231.8m and the offer will close on 14 Feb at 12 noon and starts trading on 16 Feb 2024 at 9am.   Principal Business SAM is a healthcare service provider using advanced technology for early and accurate diagnosis to detect and treat cancer, neurodegenerative and cardiovascular diseases.  SAM has strategic collaborations with public and private institutions for research and clinical work.  SAM's goal is to create a comprehensive one-stop ambulatory cancer centre to undertake the challenges to fight cancer and is one of the first to adopt proto beam therapy treatment in Singapore. Fi

A test of investors' will?

It is amazing that HL Bank is launching its 2nd IPO of June, Combine Will International Limited. Frankly, the English name of this company really sounded like one that is 'bought off-the-shelf' and is really 'testing' the will of the market.

The performance of the recent IPOs have been lacklustre and i will not be surprised if Combine Will trades below water post its IPO. On another IPO, I was informed by my DBS broker that it is no longer underwriting for China Fibertech and i wont be allocated the IPO shares and i heaved a sign of relief.

Let me do a write up on Combine Will when i managed to hold of that hard copy prospectus... (too lazy to read the online version...)

Comments